Opus Other Tuesday, June 16, 2026 +0.50 Positive

Opus Genetics to host R&D Science Forum on June 16, 2026

Opus Genetics announced an R&D Science Forum scheduled for June 16, 2026, to discuss clinical trial data and pipeline developments. The event highlights the company's gene therapy progress and regulatory milestones relevant to investors.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day